Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S ADR
(NY:
NVO
)
135.64
-5.23 (-3.71%)
Streaming Delayed Price
Updated: 1:30 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novo Nordisk A/S ADR
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
54
55
Next >
Wegovy Maker Novo Nordisk, Akero Therapeutics, Eli Lilly, Athena Consumer Acquisition, Tesla: Why These 5 Stocks Are Trending Today
October 10, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 130 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
WW Stock Soars To High. New Weight-Loss Drug Play Enjoys Oprah Winfrey Effect.
October 10, 2023
The ex WeightWatchers is reinventing itself amid boom for weight-loss drugs like Ozempic.
Via
Investor's Business Daily
Weight-Loss Drugs Aren't To Blame For The Snack Pullback. Pepsi Offers This Reason.
October 10, 2023
Weight-loss drugs aren't the reason for suppressed shopping cart spending in a shaky economy, Pepsi executives say.
Via
Investor's Business Daily
Topics
Economy
Exposures
Economy
Obesity Medication Insurance Coverage? Employers Embrace the Inclusion of Novo Nordisk's Wegovy in Health Coverage
October 10, 2023
Coverage for obesity medications, including Novo Nordisk A/S's (NYSE: NVO) Wegovy, is expected to expand among U.S.
Via
Benzinga
Why Eli Lilly Stock Crawled Higher Today
October 09, 2023
The pharmaceutical giant gets a lift from some good news on insurance coverage and a prognosticator's price-target lift.
Via
The Motley Fool
Is Ozempic Eating Into Snack Profits?
October 08, 2023
This week, Felix Salmon, Emily Peck, and Elizabeth Spiers talk about how Ozempic affects food buying habits, the rise in mortgage and interest rates, and the decrease in stock buybacks.
Via
Talk Markets
(NVO) - Analyzing Novo Nordisk's Short Interest
October 06, 2023
Via
Benzinga
Weight-Loss Drug Boom Has Another Ripple Effect - Rapid Growth Expected In Fill-Finish Market
October 09, 2023
Contract drug manufacturers are investing billions of dollars in expanding or constructing facilities that fill the injection pens used for weight-loss drugs like Novo Nordisk A/S's (NYSE: NVO)...
Via
Benzinga
Obesity Drug Boom, Split Make This Stock a Heavy Bargain
October 09, 2023
Ozempic users may be losing their appetites for sweets…but Novo Nordisk is one Danish treat that the market may only get hungrier for.
Via
MarketBeat
This Dividend Stock Just Got Hit With a Short Report. Is Now a Buying Opportunity?
October 08, 2023
Coca-Cola is the latest subject of the Bear Cave, an online publisher of reports on stock to sell short.
Via
The Motley Fool
3 Biotech Stocks Ready to Break Out in 2024
October 07, 2023
These top three biotech companies are ready to roar into the new year with promising new trials, drugs, and innovative use of AI.
Via
InvestorPlace
3 No-Brainer Growth Stocks to Buy in October
October 07, 2023
The time is right to invest in these great stocks.
Via
The Motley Fool
Shutdown Averted, Treasury Yields Flirt With 5%, Strong Payrolls Add to Fed Tightening Risk: The Week In The Markets
October 06, 2023
Catch up on the week's market highlights, from government funding drama to surging Treasury yields and an unexpectedly strong jobs report.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Snacks In The Ozempic Era: Food, Beverage Stocks Crash With Weight Loss Drugs On The Rise
October 06, 2023
Food and beverage stocks endure their toughest week since May 2022, driven by concerns over weight-loss drugs and shifting consumer behavior.
Via
Benzinga
Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger, Novo Nordisk's Weight Loss Drugs May Pose Serious Stomach Risks, Netflix's Local Content and Pricing Woes Undermine Growth in India: Today's Top Stories
October 06, 2023
Bloomberg Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger
Via
Benzinga
Better Growth Stock: Novo Nordisk vs. Pfizer
October 06, 2023
Which of these two pharmaceutical giants should you add to your portfolio?
Via
The Motley Fool
Novo Nordisk's Weight Loss Drugs Like Wegovy, Ozempic May Pose Serious Stomach Risks, Study Suggests
October 06, 2023
A recent study published in JAMA has raised concerns about the potential risks associated with popular weight loss and diabetes drugs like Novo Nordisk A/S's (NYSE: NVO), Wegovy (semaglutide), Ozempic...
Via
Benzinga
2 Reasons Why Eli Lilly's Mounjaro Might Beat Novo Nordisk's Ozempic, and 2 Reasons Why It Might Not
October 06, 2023
Eli Lilly's drug looks better on paper, but Ozempic was on the market first.
Via
The Motley Fool
ConAgra's Snack Revolution - Portion Sizes May Get A Makeover Amid Diet Drug Wave: Report
October 06, 2023
ConAgra Brands, Inc. (NYSE: CAG) could reportedly revamp the portion sizes of its snacks should the rising tide of
Via
Benzinga
Why Insulet Stock Traded Lower
October 05, 2023
Insulet Corporation (NASDAQ: PODD) shares traded lower Thursday.
Via
Benzinga
Biggest Oil Drop In A Year On Biden Security Plan, Magnificent 7 Stocks Do Not Like The New Data
October 05, 2023
To gain an edge, this is what you need to know today.
Via
Benzinga
Disney Slashes Ticket Prices For Children, US Government Ceases Free Distribution Of Merck COVID Pill, UK Deep Dives Into Amazon And Microsoft's Cloud Power: Today's Top Stories
October 05, 2023
CNBC Disney Slashes Children's Ticket Prices Amid Attendance Slump
Via
Benzinga
Exposures
COVID-19
Novo Nordisk's Wegovy Success Uplifts Denmark's Economy And Reputation, But With Caution
October 05, 2023
Novo Nordisk A/S's (NYSE: NVO) remarkable success with its weight-loss treatment, Wegovy, is not only a cause for celebration but also a source of
Via
Benzinga
Topics
Economy
Exposures
Economy
3 Dividend Stocks That Turned $25,000 into $100,000 in 10 Years -- and None of Them Is a Tech Stock
October 05, 2023
These stocks may not be done rising in value just yet.
Via
The Motley Fool
Here's the Best Big Pharma Stock of the Decade so Far (and It's Not Even Close)
October 05, 2023
This stock puts the "big" in big pharma after massive gains in recent years.
Via
The Motley Fool
Walmart Reports 'Slight Pullback' In Food Demand As 'Miracle' Weight-Loss Drug Ozempic Gains Popularity
October 05, 2023
Via
Benzinga
2 Magnificent Growth Stocks to Buy Right Now
October 04, 2023
These two biotech stocks could be big winners for patient investors.
Via
The Motley Fool
1 Stock-Split Stock to Buy Hand Over Fist in October and 1 to Avoid
October 04, 2023
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's one historically cheap stock-split stock, as well as another company that carries...
Via
The Motley Fool
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration
October 03, 2023
All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administration
Via
Benzinga
Obesity Drug Wegovy's Triumph to Catapult Novo Holdings In Golden Era Of Wealth Boost
October 03, 2023
Novo Holdings, the controlling shareholder of Novo Nordisk A/S (NYSE: NVO), is bracing for a significant influx of capital stemming from the thriving success of the weight-loss drug Wegovy.
Via
Benzinga
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
54
55
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.